Follicular Lymphoma Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 750
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Follicular Lymphoma to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Follicular Lymphoma to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Follicular Lymphoma Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Follicular Lymphoma 35
Aug 07, 2017: Kite Announces Initiation of Axicabtagene Ciloleucel CAR-T Clinical Program in the European Union 35
Jun 24, 2017: Verastem Reports Phase 2 Long-Term Follow-Up Data for Duvelisib in Patients with Double-Refractory Follicular Lymphoma and Small Lymphocytic Lymphoma at the 22nd Congress of the European Hematology Association 35
Jun 23, 2017: Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma 36
Jun 17, 2017: Updated Data from Phase IIIb MAGNIFY Study of REVLIMID (lenalidomide) and Rituximab Combination (R2) Show Clinical Activity and Responses in Relapsed/Refractory Follicular and Marginal Zone Lymphoma 37
Jun 16, 2017: BeiGene Presents Initial Phase 1 Data on BTK Inhibitor BGB-3111 Combined with Obinutuzumab at the 14th International Conference on Malignant Lymphoma and Announces Additional Planned Global Registrational Trials for BGB-3111 38
Jun 15, 2017: TG Therapeutics Announces Follow-Up Data from the Triple Combination of TG-1101, TGR-1202, and Bendamustine in Patients with DLBCL and FL at the 14th International Conference on Malignant Lymphoma 39
Jun 14, 2017: Celltrion Healthcare showcases data supporting the efficacy and safety of Truxima (CT-P10, biosimilar rituximab) in advanced follicular lymphoma and rheumatoid arthritis 39
Jun 14, 2017: Epizyme Reports Positive Interim Data from Phase 2 Trial for Tazemetostat in Relapsed or Refractory Follicular Lymphoma and DLBCL Patients 40
Jun 13, 2017: TG Therapeutics Recaps Schedule of Clinical Data Presentations of TGR-1202 at the Upcoming 14th International Conference on Malignant Lymphoma & the 22nd European Hematology Association Annual Congress 41
Jun 07, 2017: BeiGene to Present Data on BGB-3111 at the 14th International Conference on Malignant Lymphoma and to Host Conference Call 41
Jun 05, 2017: Immune Design Updates Positive Data from Lead Immuno-oncology Product candidate, G100, at ASCO Annual Meeting 42
May 31, 2017: MEI Pharma Announces Pre-Specified Response Rate Exceeded in Dose-Escalation Study of ME-401 in Chronic Lymphocytic Leukemia and Follicular Lymphoma 43
Clinical Trial Profile Snapshots 44
Appendix 747
Abbreviations 747
Definitions 747
Research Methodology 748
Secondary Research 748
About GlobalData 749
Contact Us 749
Disclaimer 749
Source 750

List of Tables
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Region, 2017* 8
Follicular Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
Proportion of Follicular Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017* 17
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Follicular Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2017* 23
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
Follicular Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 29
Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
Follicular Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34

List of Figures
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Follicular Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
Proportion of Follicular Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017* 17
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Follicular Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 24
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Follicular Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 29
Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Follicular Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34
GlobalData Methodology 748
Filed in: Pharmaceutical
Publisher : GlobalData